Inducible chloramphenicol resistance genes cat and c*ml are regulated by translation attenuation. For both genes, the leader codons that must be translated to deliver a ribosome to the induction site specify a peptide that inhibits peptidyltransferase in vitro. The antipeptidyltransferase activity of the peptides is thought to select the site of ribosome stalling that is essential for Induction. Using variations of the cat-86 leader-encoded 5-mer peptide MVKTD, we demonstrate a correlation between the in vitro antipeptidyltransferase activity and the ability of the same peptide to support induction by chloramphenicol in vivo. MVKTD Peptide bond formation during translation is catalyzed by the ribosome-associated activity peptidyltransferase (PT) (21). PT is the target for several antibiotics including chloramphenicol and anisomycin (20) . We have recently demonstrated that PT is also inhibited by the short peptides that are encoded by the leaders of attenuation regulated. chloramphenicol resistance genes (10, 12). The peptide inhibitors fall into two classes according to their sizes and specific inhibition. The leaders for inducible cat genes specify one class of PT-inhibitor peptides; the first five codons of the leaders encode 5-mer peptides that exhibit about 1/10 of the specific inhibition of chloramphenicol (10, 12) . The second class of inhibitor peptide consists of only one member, the eight-residue peptide that is encoded by the first eight codons of the cmlA leader (12). The cmlA 8-mer peptide is about one-half as inhibitory as chloramphenicol on SOS ribosomal subunits ofBacillus subtilis and is about fivefoldmore inhibitory than the cat leader peptides. Members of both classes of peptides may function similarly on the basis of their common footprints on 23S rRNA and the sensitivity of the inhibitory activity to competition by erythromycin (10). The mechanism of peptide inhibition of PT is probably not identical to that of chloramphenicol since the activities of chloramphenicol and the peptides are additive (10).
Peptide bond formation during translation is catalyzed by the ribosome-associated activity peptidyltransferase (PT) (21) . PT is the target for several antibiotics including chloramphenicol and anisomycin (20) . We have recently demonstrated that PT is also inhibited by the short peptides that are encoded by the leaders of attenuation regulated. chloramphenicol resistance genes (10, 12) . The peptide inhibitors fall into two classes according to their sizes and specific inhibition. The leaders for inducible cat genes specify one class of PT-inhibitor peptides; the first five codons of the leaders encode 5-mer peptides that exhibit about 1/10 of the specific inhibition of chloramphenicol (10, 12) . The second class of inhibitor peptide consists of only one member, the eight-residue peptide that is encoded by the first eight codons of the cmlA leader (12) . The cmlA 8-mer peptide is about one-half as inhibitory as chloramphenicol on SOS ribosomal subunits ofBacillus subtilis and is about fivefoldmore inhibitory than the cat leader peptides. Members of both classes of peptides may function similarly on the basis of their common footprints on 23S rRNA and the sensitivity of the inhibitory activity to competition by erythromycin (10) . The mechanism of peptide inhibition of PT is probably not identical to that of chloramphenicol since the activities of chloramphenicol and the peptides are additive (10) .
The anti-PT activity of the leader peptides is thought to play a critical role in the translation attenuation regulation of cat (1, 8, 11, 13, 17, 26) and cmlA (6, 33) by selecting the site of ribosome stalling (10, 12) . Thus, the in vivo synthesis of the inhibitor peptides coincides with the translation by a ribosome to the leader site at which ribosome stalling will activate downstream gene expression (1, 10) . Moreover, a missense mutation in the cat leader that prevents induction by chloram-* Corresponding author. Phone: (410) 455-2249. Fax: (410) 455-3875. phenicol causes an amino acid replacement in the 5-mer peptide that eliminates its anti-PT activity (12) .
In the present study we demonstrate that the in vitro inhibitory activity of a leader peptide correlates with the in vivo activity of the peptide in gene regulation. Examination of the peptide sensitivity of PT from several sources suggests that the target is a sequence or structure which is conserved in prokaryotic and eukaryotic ribosomes.
MATERIALS AND METHODS PT. The fragment reaction was used to assay PT (21) . The fragment reaction measures the in vitro transfer of N-formylmethionine from an endonuclease T1 fragment of tRNA to puromycin. The product of the reaction is N-formylmethionine-puromycin which is phase extracted with ethyl acetate. PT is the catalyst for the fragment reaction, and this activity is associated with the large ribosomal subunit (20) . As a source of PT activity we have used. intact ribosomes or the large (50S) subunit isolated from bacterial ribosomes. For ribosome isolation, we followed standard methods as outlined by Spedding (32) . In selected cases, PT activity can be recovered by phenol extraction of 50S ribosomal subunits and is associated with the partially deproteinized 23S rRNA (24) . Ribosomes or rRNA (0.1 to 0.15 U of optical density at 260 nm) was added to each 75 p1 of the reaction mixture. PT reaction mixtures were incubated on ice for 1 h as previously described (12 (RBS-C). The positive regulator is the translated leader sequence consisting of nine codons. Destabilization of the secondary structure results from the stalling of a ribosome in the leader with its peptidyl and amino acyl sites at leader codons 5 and 6, respectively (1). The first five leader codons and the product pentapeptide are shown in bold. These five codons are translated in delivering a ribosome to the induction site and specify the MVKTD peptide that inhibits PT in vitro (1, 12) . RBS-L is the ribosome binding site for the leader. The translation start codons for the leader, GUG, and the cat-86 coding sequence, UUG, are identified.
(Huntsville, Ala.). Peptides were purified by high-pressure reverse-phase liquid chromatography as previously described (12) .
Chloramphenicol induction ofcat-86. Bacillus subtilis BR151 cells containing the cat-86 gene on plasmid pPL708 (17) were grown at 370C to mid-log phase in Penassay broth and exposed to 2 ,ug of chloramphenicol per ml for 2 h. Chloramphenicol acetyltransferase was assayed at 25'C by the colorimetric method described by Shaw (29) . Chloramphenicol acetyltransferase specific activity is reported as micromoles of chloramphenicol acetylated per minute per milligram of protein. The amount of prqtein was measured by the Bradford method (2).
Peptide footprinting to 23S rRNA. Peptides and antibiotic footprinting to ribosomes were performed by using dimethyl sulfate as previously described (5, 10) .
Cell growth for ribosome isolation. Aeromonas hydrophila RS61-6, Pseudomonas aeruginosa PA-3-11, Escherichia coli DH5aF', and B. subtilis BR151 were grown in Luria broth (LB) medium (Gibco BRL) at 37°C. Bacillus stearothermophilus NUB 3621 was grown at 65°C in LB medium supplemented with Castenholtz salts and trace elements as described by Chen et al. (4) . Haloferax volcanii DS2 was grown at 37°C in a yeast-tryptone-salts medium described by Nieuwlandt et al. (23) . Saccharomyces cerevisiae 3871D was grown at 30°C in a medium consisting of 1% yeast extract, 2% peptone, and 2% glucose.
Site-directed mutagenesis. The leader of cat-86 was cloned into M13 vectors and subjected to oligonucleotide mutagenesis (7, 34) . The mutagenized fragment was sequenced (28) and used to replace the corresponding region in pPL703-P4 (17) .
ermC-specified methylation of nucleotide 2058 in 23S rRNA. ermC on plasmid pIM13 is constitutively expressed (19) . Replication of pIM13 is temperature sensitive in B. subtilis (19) , and even at the permissive temperature (32°C) the plasmid is frequently lost from host cells. To facilitate the isolation of uniformly methylated ribosomes from ermC-positive cells grown without erythromycin, we constructed, using PCR, an EcoRI fragment spanning the ernC gene from pIM13 and inserted it into pUB110. The fragment extends from a site between the -10 and -35 promoter sequences of ermC to the approximate middle of the putative transcription terminator for the gene (19) . Accordingly, the gene lacks a functional promoter and terminator. Hence, transcription of the gene in pUB110 depends on read-through transcription from plasmid sequences. The sequences of the primers used to construct the EcoRI fragment were 5'-ATAGAATFCAGAGCTCGTGC-3' and 5'-AAGGAATTCAGTl'lATGCATCCC-3'. The resulting plasmid, pErm, was stably maintained in B. subtilis at temperatures of up to 45°C and conferred resistance to erythromycin.
RESULTS
Amino acid substitutions in the cat-86 5-mer peptide that abolish or diminish anti-PT activity have a corresponding effect on cat-86 inducibility by chloramphenicol. The sequence of the first five residues of the cat-86 leader-encoded peptide is MVKTD ( Fig. 1) (17) . 5-mer peptides having individual amino acid changes from the sequence MVKTD were tested for anti-PT activity. For selected examples, the corresponding mutation was made in the cat-86 leader, which allowed the effect of the altered peptide on in vivo induction to be tested. In each case, general agreement was observed between the effect of an amino acid replacement on PT inhibition and its effect on inducibility by chloramphenicol (Fig. 2) . For (15, 16, 31) . Nucleotide 2058 is one of three adjacent nucleotides in 23S rRNA to which the inhibitor peptides MVKTI) and MSTSKNAD footprint (10) (Fig. 3) . We were .30
nucleotide 2058 would not interfere with the in vitro activity of the peptide as a PT inhibitor. To test this proposal, ribosomes were isolated from cells expressing ermC, on plasmid pErm, and isogenic cells not carrying ermC. The corresponding 23S rRNA was used as a template for reverse transcriptase. RNA from the ennC-positive cells caused termination of reverse transcriptase at the nucleotide preceding 2058, whereas RNA from ernC-negative cells did not cause termination at this site (Fig. 4) . Accordingly, the emiC-encoded methylase methylated nucleotide 2058.
Using these same ribosomes, we footprinted erythromycin and MVKTD, employing dimethyl sulfate as the chemical probe. Ribosomes from ennC-positive cells failed to show the characteristic erythromycin footprint, which is a reduction of dimethyl sulfate methylation of nucleotides 2058 and 2059 (18) . The erythromycin footprint was present in the rRNA from the cells not carrying the ermC gene (data not shown, but 3 . Sequence of PT center of 23S rRNA. The numbering of nucleotides is done in accordance with the E. coli system, although the ribosomes used for this study were from B. subtilis, whose 23S rRNA differs slightly in size from that of E. coli (9) . The primer used for reverse transcriptase mapping and the relationship between the nucleotides footprinted by erythromycin, peptide, and the nucleotide methylated by the ermC methylase are shown. (Fig. 3) (10) . The MVKTD footprint on the rRNA from the ermC-positive cells was very similar to that on rRNA from enmC-negative cells (Fig. 4) (10) , suggesting that the methylation of nucleotide 2058 did not alter the interaction of the peptide with the rRNA. This was confirmed by testing the response of the PT activity of the ribosomes to inhibition by MVKTD. Ribosomes from the ermC-positive or ernC-negative cells were about equally sensitive to peptide inhibition (Fig. 5) .
Erythromycin competes with the activity of MVKTD as an inhibitor of PT. Because of the overlapping footprints of erythromycin and peptide on rRNA, we have presumed that the competition results from the interference of erythromycin with the binding of the peptide. Since ribosomes from the enmC-positive cells should not bind erythromycin, we suspected that on these ribosomes erythromycin would not compete with the anti-PT activity of MVKTD. The data shown in the eubacteria B. subtilis, E. coli, P. aeruginosa, and A. hydrophia were about equally sensitive to MVKTD ( Table 1) . The PT activity of intact ribosomes from a representative of the Archaea, H. volcanii, was also sensitive to inhibition by MVKTD and insensitive to chloramphenicol (Table 1) .
Eukaryotic ribosomes are insensitive to many antibiotic inhibitors that act on bacterial ribosomes, such as chloramphenicol. Since the Archaea ribosomes were insensitive to chloramphenicol but sensitive to inhibition by MVKTD, we examined the 80S ribosomes isolated from the yeast S. cerevisiae. We observed that the PT activity of yeast ribosomes was inhibited by MVKTD and anisomycin but was insensitive to chloramphenicol (Fig. 6) . Thus, the PT activity of ribosomes from representatives of the three kingdoms was sensitive to MVKTD inhibition.
The cmL4 8-mer leader peptide is about fivefold-more inhibitory for PT of prokaryotic ribosomes than is MVKTD aIntact ribosomes were preincubated with 1 mM MVKTD or 200 ,uM chloramphenicol (CM) for 10 min, and each was then assayed for PT activity for 1 h. Inhibition by the reverse 5-mer DTKVM, at 1 mM, was less than 8% for each ribosome preparation analyzed. Activities of the uninhibited reaction mixtures ranged from 350,000 to 420,000 cpm. Yeast 80S ribosomes were exposed to various concentrations of the inhibitor peptides, the reverse 5-mers, chloramphenicol (data not shown) or anisomycin (An). The peptide was preincubated with the ribosomes for 10 min, and antibiotics were added to reactions mixes with the ribosomes but without preincubation. Chloramphenicol was not detectably inhibitory for the PT activity. (10) . Similarly, the 8-mer peptide MSTSKNAD was significantly more inhibitory for yeast 80S ribosomes than was MVKTD (Fig. 6 ). These data suggest that the 5-and 8-mer peptides have similar modes of action on the PT of prokarotic and eukaryotic ribosomes.
PT activity can be phenol extracted from B. stearothermophilus ribosomes and is sensitive to peptide inhibition. cat genes are induced poorly or not at all in E. coli, while various gram-positive hosts, including the thermophile B. stearothermophilus, support induction levels of 10-to 50-fold following the addition of low levels of chloramphenicol. Noller et al. (24) demonstrated that the rRNA phenol extracted from the ribosomes of a gram-negative thermophile, Thermus aquaticus, is catalytically active in the PT reaction, and we have shown that this activity is sensitive to inhibition by MVKTD and MSTSKNAD (10) . To determine if the resistance of PT to phenol treatment might be a characteristic of thermophiles, we examined the PT activity of B. stearothermophilus; this organism was of particular interest because it supports cat-86 induction in vivo. We observed that phenol extraction of 50S ribosomes of B. stearothermophilus generated an RNA product that retained 50 to 80% of the PT activity of the intact 50S subunits. This activity was inhibited by MVKTD (Fig. 7) . Similar phenol treatment of 50S ribosomal subunits of the mesophile B. subtilis eliminated all PT activity. It is of interest that the susceptibility of B. stearothermophilus PT activity to the inhibitor peptide followed a hierarchy; 70S ribosomes were the most resistant to inhibition, and the extracted rRNA was the form of PT that was most sensitive to inhibition by MVKTD (Fig. 7 ).
An inhibitor peptide lacks a regular structure. The PT inhibitor peptide MVKTD was examined by nuclear magnetic resonance in the absence and presence of 500 pM chloram- stearothermophilus PT activity by MVKTD. B. stearothermophilus 70S ribosomes, 50S subunits, and rRNA that was phenol extracted from the 50S subunits were tested for sensitivity to MVKTD and the reverse 5-mer DTKVM. phenicol to determine if the peptide had detectable structure in solution. No regular structure could be detected. Thus, if the peptide does assume a regular folding pattern, it must do so under conditions other than those tested, such as during the binding to its ribosomal target.
DISCUSSION
A search for a ribosome-pausing function of the cat leader was initiated to resolve two obviously contradictory features of translation attenuation regulation of cat genes: cat genes are induced by chloramphenicol, an antibiotic that blocks translation at random sites in mRNA, yet cat expression depends on the precise stalling of a ribosome with its amino acyl site at leader codon 6 (1). We initially observed that the codons which precede the leader stall site participate in selecting the site of stalling (22, 25, 26) . This leader function now appears to be a direct result of the antiribosome activity of the product pentapeptide (12) .
Expression of the 5-mer peptide MVKTD within cells does not slow growth (25) , indicating that the anti-PT activity of the leader peptide does not interfere with overall protein synthesis in vivo. We have further shown that the 5-mer peptide communicates specifically with its translating ribosome in vivo and alters the function of that ribosome (27) . Our model therefore proposes that the 5-mer peptide acts exclusively in cis to pause elongation of its translating ribosome by inhibiting PT. To critically examine the apparent correlation between the role of the 5-mer peptide as an inhibitor of PT and its role in the regulation of cat-86, we constructed several variations of the amino acid sequence of the 5-mer that either eliminated or diminished its activity as a PT inhibitor or had no effect on the inhibition. In each case, when the corresponding mutation was made in the cat-86 leader, the level of induction by chloramphenicol paralleled the level of PT inhibition observed in vitro.
These data therefore support the proposal that the antiribosome activity of the peptides is necessary for regulation by translation attenuation.
The anti-PT activity of MVKTD can be demonstrated by using ribosomes from organisms representing the three kingdoms. Moreover, the PT activity that is phenol extracted from 50S ribosomes of gram-negative and gram-positive thermophiles is also subject to peptide inhibition. Thus, the target for the action of the peptides appears to be a highly conserved sequence or structure that probably resides in 23S or 23S-like rRNA.
MVKTD alters the ability of dimethyl sulfate to methylate three nucleotides in 23S rRNA, nucleotides 2058, 2059 and 2060. In vivo methylation of 2058 by the ermC-encoded methylase did not interfere with the inducibility of cat-86 or the anti-PT activity of the peptide. Thus, the interaction of peptide with nucleotide 2058 and the immediately adjacent nucleotides might be secondary to a site of primary binding elsewhere in the rRNA. Anti-PT antibiotics footprint to nucleotides in the region of 2451 (18) (Fig. 3) . We are currently determining if MVKTD footprints to nucleotides in that region of rRNA.
The cmlA 8-mer peptide MSTSKNAD is more inhibitory than the cat leader pentapeptides MVKTD, MKKTD, and MKKSE, although they function in qualitatively similar manners. A sequence similarity among the four peptides can be seen in the four C-terminal amino acids, suggesting that the C-terminal end of the molecules may be essential to a function that is common to all the peptides, such as PT inhibition. Consistent with this idea is the fact that the N-terminal amino acid of the cat-86 5-mer can be switched between two very unlike amino acids, Met and Ser, while full inhibitory activity is retained (10) . This also suggests that the inhibitory domain of the cat peptides and perhaps the cmlA peptide may not be the N terminus. This suggestion is compatible with our view of the mechanism by which the peptides regulate translation in vivo: inhibition of PT must not occur until the final amino acid of the 5-or 8-mer has been incorporated into the nascent peptide. Precisely why the 8-mer is more inhibitory in vitro than the cat 5-mers is not known. Efforts are under way to increase the activity of the cat-86 5-mer by modifications of its sequence and by moderate changes in the size of the peptide.
